Search results
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga· 5 days agoMerck reported improvement in cancer patients receiving its Keytruda regimen. Enrolling 698...
Calliditas' survival data salvage midphase cancer trial after primary endpoint miss
FierceBiotech· 5 hours agoCalliditas Therapeutics had a typical to-do list for its midphase head and neck cancer study. Step...
Merck's KEYTRUDA shows survival benefit in gastric cancer trial By Investing.com
Investing.com· 6 days agoMerck & Co., Inc., a leading pharmaceutical company, announced positive results from the Phase 3...
Dow Jones Drug Giant Merck, Nvidia Eye Buy Points In Current Stock Market
Investor's Business Daily· 20 hours agoMerck stock backstory: On April 25, Merck jumped after the Dow Jones stalwart topped Wall Street's...
What is the Outlook for a Mesothelioma Diagnosis?
Daily Sundial· 8 hours agoOver the past 15 or 20 years, a rare form of cancer known as mesothelioma has become increasingly common – affecting as many as 3,000 Americans each year. What is Mesothelioma ...
CG follows big IPO with new results for bladder cancer drug
BioPharma Dive via Yahoo Finance· 4 days agoNewly disclosed Phase 3 results presented Friday match findings the biotech disclosed last year,...
IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
WKBN 27 Youngstown· 5 hours agocancer targeted mid-year 2024Targeting initial Phase 2 expansion for IDE161 in HRD solid tumors and Phase 1 FPI for IDE161 in combination with Merck's anti-PD-1 therapy < ...
Combo Therapy May Be Advance Against Liver Cancer
US News & World Report· 1 day agoA new combination therapy appears to boost the response rate for liver cancer patients receiving immunotherapy, according to results from a phase 2 clinical trial. The combo ...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 5 days agoThe company’s R&D investment strategy focuses on the area of immuno-oncology and particularly the expansion of its portfolio after the success of its...
Merck reports data from Phase III gastric cancer treatment trial
Clinical Trials Arena via Yahoo Finance· 5 days agoFollowing the earlier results, the US Food and Drug Administration (FDA) gave accelerated approval...
